radiopharmaceutical excellence

The Future of Precision Medicine

Indiana is the Radiopharmaceutical Capital of the World℠, setting the global standard for discovery, production, and delivery of life-saving radiopharmaceutical therapies.

From Idea to Impact

Indiana leads the way in radiopharmaceutical innovation with an unmatched ecosystem that drives the development, manufacturing, and global delivery of cutting-edge therapies.

The only U.S. supplier of four critical radioisotopes essential for diagnostic and therapeutic applications
#1 in U.S. life sciences exports
#1 in U.S. pharmaceutical exports

Backed by a strong foundation in research, logistics, and workforce development initiatives, Indiana provides a secure and scalable infrastructure, top-tier talent, and regulatory expertise necessary to accelerate innovation and meet growing global demand.

Specialized isotope production facilities
State-of-the-art clean rooms
Radiopharmaceutical cyclotrons
Integrated research platforms

Impact IN

2024: By the Numbers

Indiana’s life sciences industry is gaining strength as a global life sciences leader. Our robust ecosystem, strategic partnerships, and strong investments are propelling Indiana to the forefront of medical advancements and transforming global health.

#1

in life sciences exports

$27B total

926

Patents granted

#1

in pharmaceutical exports

$21B total

100

New FDA approvals

Partners in Radiopharmaceuticals